RT Journal Article SR Electronic T1 Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19) JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.04.28.20082743 DO 10.1101/2020.04.28.20082743 A1 Katja Radon A1 Elmar Saathoff A1 Michael Pritsch A1 Jessica Michelle Guggenbühl Noller A1 Inge Kroidl A1 Laura Olbrich A1 Verena Thiel A1 Max Diefenbach A1 Friedrich Riess A1 Felix Forster A1 Fabian Theis A1 Andreas Wieser A1 Michael Hoelscher A1 the KoCo19 collaboration group # YR 2020 UL http://medrxiv.org/content/early/2020/05/02/2020.04.28.20082743.abstract AB Background The SARS-CoV-2 pandemic is leading to the global introduction of public health interventions to prevent the spread of the virus and avoid the overload of health care systems, especially for the most severely affected patients. Scientific studies to date have focused primarily on describing the clinical course of patients, identifying treatment options and developing vaccines. In Germany, as in many other regions, current tests for SARS-CoV2 are not being conducted on a representative basis and in a longitudinal design. Furthermore, knowledge about the immune status of the population is lacking. Yet these data are needed to understand the dynamics of the pandemic and to thus appropriately design and evaluate interventions. For this purpose, we recently started a prospective population-based cohort in Munich, Germany, with the aim to better understand the state and dynamics of the pandemic.Methods In 100, randomly selected constituencies out of 755, 3,000 Munich households are identified via random route and offered enrollment into the study. All household members are asked to complete a baseline questionnaire and subjects ≥14 years of age are asked to provide a venous blood sample of ≤3 ml for the determination of SARS-CoV-2 IgG/IgA status. The residual plasma and the blood pellet are preserved for later genetic and molecular biological investigations. For twelve months, each household member is asked to keep a diary of daily symptoms, whereabouts and contacts via WebApp. If symptoms suggestive for COVID-19 are reported, family members, including children <14 years, are offered a pharyngeal swab taken at the Division of Infectious Diseases and Tropical Medicine, LMU University Hospital Munich, for molecular testing for SARS-CoV-2. In case of severe symptoms, participants will be transferred to a Munich hospital. For one year, the study teams re-visits the households for blood sampling every six weeks.Discussion With the planned study we will establish a reliable epidemiological tool to improve the understanding of the spread of SARS-CoV-2 and to better assess the effectiveness of public health measures as well as their socio-economic effects. This will support policy makers in managing the epidemic based on scientific evidence.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project is funded by the Bavarian State Ministry of Science and Art, the LMU Klinikum München and Helmholtz Zentrum München. The funding bodies do not play a role in the design of the study and collection, analysis, nor in interpretation of data or in writing the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData of this is not yet available as this is a study protocol.